Although human ACE2 transgenic mice infected with SARS-CoV-2 have been reported to study the pathogenicity of the virus[5, 16], the evaluation of vaccines in this model is limited because of the limited animal body size and the nonsystematic characteristics of the infection process. This evidence concerns the gene ACE2 and infection.